Apple allergy is common in patients allergic to birch pollen, and this is defined as 'birch-apple syndrome'. Allergens responsible for cross-reactivity belong to the pathogenesis-related-10 family, and high homology in the amino acid sequences of the major allergens Bet v 1 from birch and Mal d 1 from apple has been demonstrated. Here we review the literature on the treatment of birch-apple syndrome by allergen immunotherapy. The only allergen immunotherapy method available thus far is based on the administration of birch-pollen extracts, through the subcutaneous or sublingual route, to induce tolerance to Bet v1 and to the homologous allergen Mal d 1. However, the studies performed thus far show modest efficacy, and thus other methods of immunotherapy should be investigated.

Allergen immunotherapy for birch-apple syndrome: what do we know? / Incorvaia, Cristoforo; Ridolo, Erminia; Mauro, Marina; Russello, Marina; Pastorello, Elide. - In: IMMUNOTHERAPY. - ISSN 1750-743X. - 9:15(2017), pp. 1271-1278-1278. [10.2217/imt-2017-0040]

Allergen immunotherapy for birch-apple syndrome: what do we know?

Ridolo, Erminia
;
Pastorello, Elide
2017-01-01

Abstract

Apple allergy is common in patients allergic to birch pollen, and this is defined as 'birch-apple syndrome'. Allergens responsible for cross-reactivity belong to the pathogenesis-related-10 family, and high homology in the amino acid sequences of the major allergens Bet v 1 from birch and Mal d 1 from apple has been demonstrated. Here we review the literature on the treatment of birch-apple syndrome by allergen immunotherapy. The only allergen immunotherapy method available thus far is based on the administration of birch-pollen extracts, through the subcutaneous or sublingual route, to induce tolerance to Bet v1 and to the homologous allergen Mal d 1. However, the studies performed thus far show modest efficacy, and thus other methods of immunotherapy should be investigated.
2017
Allergen immunotherapy for birch-apple syndrome: what do we know? / Incorvaia, Cristoforo; Ridolo, Erminia; Mauro, Marina; Russello, Marina; Pastorello, Elide. - In: IMMUNOTHERAPY. - ISSN 1750-743X. - 9:15(2017), pp. 1271-1278-1278. [10.2217/imt-2017-0040]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2835228
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 12
social impact